Kennedy Capital Management, Inc. Iovance Biotherapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $524,510 - $1.04 Million	118,133 Added 52.29%	344,042 $1.57 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $978,559 - $1.65 Million	-182,567 Reduced 44.69%	225,909 $1.59 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $855,264 - $1.27 Million	-154,659 Reduced 27.46%	408,476 $2.5 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $620,959 - $1.1 Million	-110,491 Reduced 16.4%	563,135 $3.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $87,466 - $120,323	9,178 Added 1.38%	673,626 $6.45 Million
Q2 2022 Aug 10, 2022	BUY	$6.38 - $18.33 $1.47 Million - $4.23 Million	230,990 Added 53.29%	664,448 $7.34 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $256,984 - $396,477	20,758 Added 5.03%	433,458 $7.22 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $190,341 - $317,772	-11,501 Reduced 2.71%	412,700 $7.88 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $962,188 - $1.26 Million	47,282 Added 12.54%	424,201 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $5.54 Million - $11.2 Million	339,486 Added 906.92%	376,919 $9.81 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $107,770 - $197,685	-3,759 Reduced 9.13%	37,433 $1.19 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $11,131 - $19,953	-397 Reduced 0.95%	41,192 $1.91 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $8,852 - $11,579	-319 Reduced 0.76%	41,589 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $7,618 - $11,480	280 Added 0.67%	41,908 $1.15 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $215,662 - $428,787	-11,037 Reduced 20.96%	41,628 $1.25 Million
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $8,274 - $13,558	-461 Reduced 0.87%	52,665 $1.46 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $387,234 - $559,650	-21,525 Reduced 28.83%	53,126 $967,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $730,086 - $1.83 Million	74,651 New	74,651 $1.83 Million

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

239M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $977M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account